Suppr超能文献

阴道给予米索前列醇用于引产术前宫颈成熟和引产的不同给药方案比较。

A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction.

作者信息

Wing D A, Paul R H

机构信息

Department of Obstetrics and Gynecology, University of Southern California School of Medicine, USA.

出版信息

Am J Obstet Gynecol. 1996 Jul;175(1):158-64. doi: 10.1016/s0002-9378(96)70267-3.

Abstract

OBJECTIVE

Our purpose was to compare two dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and induction of labor.

STUDY DESIGN

Five hundred twenty-two patients with indications for induction of labor and unfavorable cervices were randomly assigned to one of two dosing regimens of vaginally administered misoprostol. Twenty-five microgram tablets of misoprostol were placed in the posterior vaginal fornix either every 3 hours to a maximum of eight doses or every 6 hours to a maximum of four doses. The maximal period of cervical ripening was 24 hours regardless of the number of misoprostol doses administered. Medication was not given after either spontaneous rupture of membranes or the beginning of active labor.

RESULTS

Among 522 patients enrolled, 261 were randomized to receive misoprostol every 3 hours and 261 to receive misoprostol every 6 hours. The average interval from start of induction to vaginal delivery was shorter in the 3-hour dosing group (1311.74 +/- 785.14 minutes) than in the 6-hour dosing group (1476.96 +/- 805.30 minutes) (p < 0.05). Oxytocin augmentation of labor occurred more commonly in the 6-hour dosing group (51.4%) than in the 3-hour dosing group (41.8%) (p < 0.05) [corrected]. There were no significant differences between routes of delivery. Overall, 108 patients (20.8%) were delivered by cesarean section. There was a slightly higher prevalence of tachysystole (six or more uterine contractions in a 10-minute window for two consecutive 10-minute periods) in the 3-hour group (14.6%) than in the 6-hour group (11.2%), but this difference was not statistically different. There were no significant differences in the frequency of uterine hyperstimulation or hypertonus. There was no significant difference between groups in the frequency of abnormal fetal heart rate tracings, meconium passage, 1- or 5-minute Apgar scores < 7, neonatal resuscitations, or admissions to the neonatal intensive care unit.

CONCLUSIONS

Vaginally administered misoprostol is an effective agent for cervical ripening and induction of labor. Patients with the 6-hour dosing schedule had longer intervals to delivery, more frequently required oxytocin augmentation, and had more failed inductions than did patients with 3-hour dosing. Further investigation to characterize the safety of misoprostol is needed.

摘要

目的

我们的目的是比较阴道给药米索前列醇用于引产术前宫颈成熟和引产的两种给药方案。

研究设计

522例有引产指征且宫颈条件不佳的患者被随机分配至阴道给药米索前列醇的两种给药方案之一。25微克米索前列醇片每3小时置于阴道后穹窿,最多8剂;或每6小时给药,最多4剂。无论米索前列醇给药剂量多少,宫颈成熟的最长时间为24小时。胎膜自然破裂或进入活跃期分娩后不再给药。

结果

在纳入的522例患者中,261例随机接受每3小时一次米索前列醇治疗,261例接受每6小时一次米索前列醇治疗。3小时给药组从引产开始至阴道分娩的平均间隔时间(1311.74±785.14分钟)短于6小时给药组(1476.96±805.30分钟)(p<0.05)。引产时使用缩宫素加强宫缩在6小时给药组(51.4%)比3小时给药组(41.8%)更常见(p<0.05)[校正后]。分娩方式之间无显著差异。总体而言,108例患者(20.8%)通过剖宫产分娩。3小时组宫缩过速(连续两个10分钟时段内10分钟窗口内出现6次或更多次子宫收缩)的发生率(14.6%)略高于6小时组(11.2%),但这种差异无统计学意义。子宫过度刺激或高张的频率无显著差异。两组间异常胎心监护、羊水胎粪污染、1分钟或5分钟Apgar评分<7、新生儿复苏或入住新生儿重症监护病房的频率无显著差异。

结论

阴道给药米索前列醇是一种有效的宫颈成熟和引产药物。与3小时给药方案的患者相比,6小时给药方案的患者分娩间隔时间更长,更频繁需要缩宫素加强宫缩,引产失败更多。需要进一步研究以明确米索前列醇的安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验